HIV-positive TB patients on ART (antiretroviral therapy) in High income (World Bank)
High income (World Bank): HIV-positive TB patients on ART (antiretroviral therapy) was 81.0% in 2024. ▲ Rising
HIV-positive TB patients on ART (antiretroviral therapy) in High income (World Bank), 2003–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hiv-positive tb patients on art (antiretroviral therapy) in High income (World Bank) is 81.0%, measured in 2024.
The figure is up 2.5% on the previous year and up 19.1% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in High income (World Bank) peaked at 94.0% in 2010 and was at its lowest, 24.0%, in 2004.
The long-run direction has been consistently rising across the 22 years of available data.
HIV-positive TB patients on ART (antiretroviral therapy) in High income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 71.0% | — |
| 2004 | 24.0% | -66.2% |
| 2005 | 36.0% | +50.0% |
| 2006 | 48.0% | +33.3% |
| 2007 | 31.0% | -35.4% |
| 2008 | 32.0% | +3.2% |
| 2009 | 75.0% | +134.4% |
| 2010 | 94.0% | +25.3% |
| 2011 | 74.0% | -21.3% |
| 2012 | 71.0% | -4.1% |
| 2013 | 74.0% | +4.2% |
| 2014 | 68.0% | -8.1% |
| 2015 | 80.0% | +17.6% |
| 2016 | 65.0% | -18.8% |
| 2017 | 64.0% | -1.5% |
| 2018 | 70.0% | +9.4% |
| 2019 | 72.0% | +2.9% |
| 2020 | 69.0% | -4.2% |
| 2021 | 77.0% | +11.6% |
| 2022 | 78.0% | +1.3% |
| 2023 | 79.0% | +1.3% |
| 2024 | 81.0% | +2.5% |
Biggest year-on-year movements
Years where HIV-positive TB patients on ART (antiretroviral therapy) in High income (World Bank) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2009 | +134.4% | 32.0% | 75.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 45.3% | 24.0% | 75.0% | 7 |
| 2010s | 73.2% | 64.0% | 94.0% | 10 |
| 2020s | 76.8% | 69.0% | 81.0% | 5 |
More health data for High income (World Bank)
- Measles - number of reported cases, gaps filled 25,070 (2025)
- Diphtheria - number of reported cases, gaps filled 235 (2025)
- Total tetanus - number of reported cases, gaps filled 205 (2025)
- Pertussis - number of reported cases, gaps filled 178,482 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Number of under-five deaths, annual growth rate -1.48 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate 0.1729 % change on previous year (2024)
- Number of infant deaths, annual growth rate -1.31 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -56.94 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -56.32 % change on previous year (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in High income (World Bank)?
- Hiv-positive tb patients on art (antiretroviral therapy) in High income (World Bank) was 81.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in High income (World Bank)?
- The highest recorded value was 94.0% in 2010.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in High income (World Bank)?
- The lowest recorded value was 24.0% in 2004.
- How does High income (World Bank) rank for hiv-positive tb patients on art (antiretroviral therapy)?
- High income (World Bank) ranks 8th out of 11 groups with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in High income (World Bank)?
- Over the last ten years it is up 19.1%. The long-run trend across the full record is rising.
- Where does this High income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).